Molecules bearing fluorine are increasingly prevalent
in pharmaceuticals,
agrochemicals, and functional materials. The cyanodifluoromethyl group
is unique because its size is closer than that of any other substituted
difluoromethyl group to the size of the trifluoromethyl group, but
its electronic properties are distinct from those of the trifluoromethyl
group. In addition, the presence of the cyano group provides synthetic
entry to a wide range of substituted difluoromethyl groups. However,
the synthesis of cyanodifluoromethyl compounds requires multiple steps,
highly reactive reagents (such as DAST, NSFI, or IF5),
or specialized starting materials (such as α,α-dichloroacetonitriles
or α-mercaptoacetonitriles). Herein, we report a copper-mediated
cyanodifluoromethylation of aryl and heteroaryl iodides and activated
aryl and heteroaryl bromides with TMSCF2CN. This cyanodifluoromethylation
tolerates an array of functional groups, is applicable to late-stage
functionalization of complex molecules, yields analogues of FDA-approved
pharmaceuticals and fine chemicals, and enables the synthesis of a
range of complex molecules bearing a difluoromethylene unit by transformations
of the electron-poor CN unit. Calculations of selected steps of the
reaction mechanism by Density Functional Theory indicate that the
barriers for both the oxidative addition of iodobenzene to [(DMF)CuCF2CN] and the reductive elimination of the fluoroalkyl product
from the fluoroalkyl copper intermediate lie in between those of [(DMF)CuCF3] and [(DMF)CuCF2C(O)NMe2].